July 21-23 ,2019
Watch 25+ sessions streamed LIVE from a stellar line-up of investing and trading experts!
You need to be logged in to view this video
Earlier this month, GW Pharmaceuticals reshaped the way many people view cannabis when the company reported positive Stage 3 Clinical data for its Epidiolex product. For thousands of years, people all over the world used cannabis for a medicine. During this topic, Michael Berger, President of Technical420.com, will discuss how cannabis could shake up the pharmaceutical industry through the development of less harmful treatments for various illnesses.